TRIP13 and non-small cell lung carcinoma: To investigate the relationship between MT and TRIP13 in NSCLC cells, first, we treated cells with MT and examined the RNA and protein expression of TRIP13. Compared to the control group (0 mM MT), treatment with MT resulted in a significant decrease in the expression of TRIP13 at both the RNA (Fig. 3A, B) and protein levels (Fig. 3C, D) for both cell lines.